FW First Wave BioPharma, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the First Wave BioPharma, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 3 April 2024 (Cession). Among the most active insiders: SAPIRSTEIN JAMES. All data is openly available.
€38,307
14 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate First Wave BioPharma, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 April 2024
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
▼ Chairman and CEO · Executives · 1 Apr 2024
174 shares @ US$4.2294 3.0% of flow Common Stock SEC:0001104659-24-043156:0
▼ Chief Financial Officer · Executives · 1 Apr 2024
75 shares @ US$4.2294 2.2% of flow Common Stock SEC:0001104659-24-043154:0
▼ Chief Financial Officer · Executives · 15 Mar 2024
1,120 shares @ US$4.96 37.7% of flow Common Stock SEC:0001104659-24-036138:0
▼ Chairman and CEO · Executives · 15 Mar 2024
1,887 shares @ US$4.96 37.3% of flow Common Stock SEC:0001104659-24-036143:0
◆ President & COO · Executives · 13 Mar 2024
15,400 shares Common Stock, par value $0.0001 per share SEC:0001493152-24-010163:0
◆ Director · Executives · 13 Mar 2024
440 shares Common Stock, par value $0.0001 per share SEC:0001493152-24-010162:0
▼ Chief Financial Officer · Executives · 12 Jan 2024
98 shares @ US$4.20 2.8% of flow Common Stock SEC:0001104659-24-004460:0
▼ Chairman, President and CEO · Executives · 12 Jan 2024
166 shares @ US$4.20 2.8% of flow Common Stock SEC:0001104659-24-004458:0
◆ Director · Executives · 2 Jan 2024
19,633 shares 0Common Stock SEC:0001104659-24-001436:0
◆ Director · Executives · 2 Jan 2024
19,633 shares 0Common Stock SEC:0001104659-24-001440:0
◆ Director · Executives · 2 Jan 2024
19,633 shares 0Common Stock SEC:0001104659-24-001439:0
◆ Director · Executives · 2 Jan 2024
19,633 shares 0Common Stock SEC:0001104659-24-001438:0
◆ Chief Financial Officer · Executives · 29 Dec 2023
12,614 shares 0Common Stock SEC:0001104659-24-001025:0
◆ Chairman, President and CEO · Executives · 29 Dec 2023
17,660 shares 0Common Stock SEC:0001104659-24-001026:0
▼ Chief Financial Officer · Executives · 4 Oct 2023
1,676 shares @ US$0.29 3.4% of flow Common Stock SEC:0001104659-23-107483:0
▼ President and CEO · Executives · 4 Oct 2023
2,764 shares @ US$0.29 3.3% of flow Common Stock SEC:0001104659-23-107481:0
▼ Director · Executives · 15 Sept 2023
10 shares @ US$0.43 0.2% of flow Common Stock SEC:0001104659-23-101684:0
▼ Director · Executives · 31 Aug 2023
6,053 shares @ US$0.30 99.8% of flow Common Stock SEC:0001104659-23-098422:0
▼ Chief Financial Officer · Executives · 3 Jul 2023
1,977 shares @ US$1.54 20.6% of flow Common Stock SEC:0001104659-23-078145:0
▼ President and CEO · Executives · 3 Jul 2023
3,349 shares @ US$1.54 20.5% of flow Common Stock SEC:0001104659-23-078144:0
▼ President and CEO · Executives · 3 Apr 2023
3,347 shares @ US$2.50 33.2% of flow Common Stock SEC:0001104659-23-042156:0
▼ Chief Financial Officer · Executives · 3 Apr 2023
1,975 shares @ US$2.50 33.4% of flow Common Stock SEC:0001104659-23-042170:0
◆ Director · Executives · 3 Jan 2023
84,745 shares 0Common Stock SEC:0001104659-23-001225:0
◆ Director · Executives · 3 Jan 2023
84,745 shares 0Common Stock SEC:0001104659-23-001231:0
◆ President and CEO · Executives · 3 Jan 2023
300,000 shares 0Common Stock SEC:0001104659-23-001228:0
25 of 29 declarations
Load more (4 remaining) 关于 First Wave BioPharma, Inc. First Wave BioPharma, Inc. 是一家生物制药公司，专注于开发胃肠道疾病的治疗方法。它在纳斯达克上市，股票代码为FWBI。